Showing results (341-350 of 351) with videos related to
Sort By:
Pageof 36
European Journal of Cancer (Oxford, England : 1990)|September 7, 2019
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversionAna Lluch, Ana M González-Angulo, David Casadevall, et al.Nature Communications|May 21, 2024
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strainsShixia Wang, Kun-Wei Chan, Danlan Wei, et al.Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunctionBruce J Baum, Ilias Alevizos, Changyu Zheng, et al.ACS Synthetic Biology|March 23, 2026
Quantitative Dissection of Agrobacterium Virulence to Generate a Synthetic Ti PlasmidMitchell G Thompson, Liam D Kirkpatrick, Matthew J Szarzanowicz, et al.Biorxiv : the Preprint Server for Biology|February 3, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Experimental & Molecular Medicine|July 5, 2019
Author Correction: The wide utility of rabbits as models of human diseasesPedro J Esteves, Joana Abrantes, Hanna-Mari Baldauf, et al.Experimental & Molecular Medicine|May 24, 2018
The wide utility of rabbits as models of human diseasesPedro J Esteves, Joana Abrantes, Hanna-Mari Baldauf, et al.Journal of Alzheimer'S Disease : JAD|January 14, 2026
Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohortJing Yuan, Yaoda Hu, Feng Feng, et al.Emerging Microbes & Infections|April 7, 2025
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trialsZoe Moodie, Shuying Sue Li, Elena E Giorgi, et al.Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Pageof 36